What I was saying was based on recent materials. And, yes, if you look at other posts, you'll see many instances where some (many?) members of this forum say, with knee-jerk frequency, that you 'must' bridge to anyone reporting an INR below about 2.0. In fact, when my INR was low, briefly, and I said that I couldn't afford to bridge, complaints were made about me to the person who runs Valvereplacement.org because I wasn't bridging. There seems to be a strong, pervasive feeling among many here that it is essential in ANY and ALL cases when an INR is below 2.0 that you MUST bridge -- even if the guidelines I already posted links to say the contrary.
In another thread, there's an unfortunate member who had some pretty disastrous bleeding following knee surgery possibly because the Lovenox contributed to the hemorrhaging in the knee.
I'm not against following medical guidelines -- but these should probably be based on recent research and, if possible, with the advice from a physician whose knowledge is up to date.
I wasn't talking about patients with A-Fib not needing to keep their INRs in range, or suggesting that they shouldn't need to bridge. I wasn't talking about others who don't fit into the 'bileaflet valve, aortic valve, more than 3 months post-op' group.
Certainly, all of what I write -- or what ANYONE writes - or even what physicians write - is based on 'opinion.' Any of us (even those hallowed doctors) can prefer to selectively agree with whichever sources they choose to agree with and to discount the rest. Hell, in Pakistan, people are refusing to take Polio vaccine because it's an American plot to sterilize children. We can believe what we want to believe. Personally, I choose to give some validity to the materials I've frequently quoted from Duke and other papers that discount the risk of a low INR, temporarily, in people meeting certain conditions. These guidelines don't give odds of having a stroke in these individuals - clearly a 1 in 100 chance is unacceptable - the risks were apparently so low for this group that it was deemed safe just to increase the daily dose until the patient was in range. (1 in 1 million seems low, unless you're that unlucky one -- but seems much more acceptable than the 1 in 100 that you seem to be quoting as clinical fact).
You said that it's 'a known fact the risks of having a stroke are 1-2% every year you have a mechanical valve.' Then, according to your known 'fact', since I'm in year 21, I'm at somewhere between a 21% and a 42% risk of having a stroke? In 10 years - if I don't have a stroke by then -- my risks would be between 31% and 62%? And, if I should somehow last another 30 years with this old valve, then my risks would be between 51% and dead. Right?
I'm glad to see that the bleeding issue of the person who started this thread has been resolved.
Lets hope that our doctors -- if we can afford them -- are up to date, but conservative and careful enough (but not unduly conservative) to provide good advice for ongoing anticoagulation and for any procedures -- no matter how minor -- so that we neither have strokes or awful consequences from over anticoagulating.
Again, the only reason I even respond to post that I think are dangerous or go against what most doctors or guidelines , and even most patients who HAVE been on Coumadin for years will say is so new people looking for information will know the majority of people probably disagree with your "facts"
First of course many, most people WILL suggest if you drop below 2, you should talk to your doctor about bridging to hopefully avoid a stroke. Since many /most studies show clots increase with INRs below range. That is hardy the same as saying being below 2.0 being "an instant death sentence if you've got a bileaflet valve", like your statement would make it seem that many people or even someone says around here..
As for your sarcastic argument against my pointing out that the risk of having a stroke is between 1-2 percent every year, wether you choose to believe it or not NO I'm not saying anything close to
"You said that it's 'a known fact the risks of having a stroke are 1-2% every year you have a mechanical valve.' Then, according to your known 'fact', since I'm in year 21, I'm at somewhere between a 21% and a 42% risk of having a stroke? In 10 years - if I don't have a stroke by then -- my risks would be between 31% and 62%? And, if I should somehow last another 30 years with this old valve, then my risks would be between 51% and dead. Right?"
NO Each year starts fresh and that year your chances of having a clot are 1-2%. If you want to make it cumulative, it doesn't mean in your 20th year you have a 20-40% of having a clot THAT year, that simply means by the time someone has a mechanical valve say 20 years at the 1% risk, odds are 20% they will have had an "event" since they got the valve, or even for the 2%-- 40% of the people who've had their mechanical valve will have had an event. Even then, that means 60% of the people who've had their mechanical valve 20 years will not have had a problem at all. So yes the risks are low, BUt there are things you can choose to do or not do that make your odds better.
Are you saying that the majority of people who DO have strokes past their 1st 3 months didn't have INR either too low in cases of clot strokes or too high incases of brain bleed (that weren't caused by traums or falls) strokes? IF that is the case and to quote you "more recent guidelines, with more recent valves, don't stress the importance of forming a clot on the valve" Well IF that was the case why would they even reccomend people with mechanical valves take coumadin and the risks that CAN (not will) go along with that such as brain or internal bleeds?
IF you or anyone else chooses not to believe the risk of a clot is 1-2 % every year you have a mech valve oh well, and that is the average, it is also well known and accepted that there are times when your risk of a clot go up, like low INR either because of stopping and starting for procedures or just because things happen and it went low.
There ARE hundreds of studies showing that to the point it has become a known accepted fact that having a mechanical valve is a risk of forming clots AND so you need to take Coumadin or another anticoagulant and that increases your chances of a bleed. Its why many people choose to have tissue valves, with the increase risks of "events' during REDOs. Every valve study since the beginning shows the rates of Clots and rates for bleeds for a reason. Every article about valve choice discusses the fact mechanical valves increase your odds of having a clot and so you need to take coumadin, The average is about 1-2 percent each year for the valves in use today.
Even the ON-X one of the newest, with supposedly the best chances of avoiding clots, beside the midterm results of the PROACT trials that showed patients with the lower INR had more strokes and the higher (normal INR plus aspirin) had more bleeds "The low-anticoagulant group had 2.5 bleeding events per patient-year, vs 4.4 per patient year in the control group, but the stroke rate was 1.3% per patient-year in the low-anticoagulant group vs 0.4% per patient-year in the control group. For the combined end point of stroke and thrombotic and bleeding events, the rates were 3.8% per patient-year in the low-anticoagulant group and 4.9% per patient-year in the control group".
and in the trial these were followd by the best centers and all home test.
Also the midterm, 5 year results showed the risk of clots were about 1% a year
Between 2003 and 2008, 737 patients underwent either aortic valve replacement (n = 400), mitral valve replacement (n = 282), or double-valve replacement (n = 55). Longitudinal performance, freedom evaluation, and risk analysis were assessed with regard to major thromboembolism and hemorrhage. Risk modeling was performed with 16 variables inclusive of age, atrial fibrillation, concomitant coronary artery bypass grafting, New York Heart Association class, and ventricular dysfunction.
RESULTS:
Early mortality was 2.5% (n = 10) for aortic valve replacement and 3.2% (n = 9) for mitral valve replacement. Late mortality for aortic valve replacement was 4.8% per patient-year and 6.0% per patient-year for mitral valve replacement.
Five-year freedom from major thromboembolism was 96.5% ± 1.2% for aortic valve replacement and 97.7% ± 0.9% for mitral valve replacement. Five-year freedom from hemorrhage was 93.6% ± 1.8% for aortic valve replacement and 95.7% ± 1.5% for mitral valve replacement. Concomitant coronary artery bypass grafting was predictive of major thromboembolism after aortic valve replacement (hazard ratio, 5.3; P = .02) and antithrombotic hemorrhage after mitral valve replacement (hazard ratio, 4.7; P = .03). No other independent predictors of major thromboembolism or hemorrhage were identified. One thrombosed mitral prosthesis was observed after deliberate discontinuation of anticoagulation. The major thromboembolic events occurred with variation of international normalized ratio levels inclusive of subtherapeutic levels. The majority of hemorrhagic events occurred with high international normalized ratio levels.
http://www.ncbi.nlm.nih.gov/pubmed/20546795